Page last updated: 2024-11-02

piracetam and Dysarthosis

piracetam has been researched along with Dysarthosis in 3 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Research Excerpts

ExcerptRelevanceReference
" Levetiracetam monotherapy at a dosage of 40 mg/kg/day improved the clinical findings, and seizures were controlled at the end of the first month of treatment."1.38Acquired epileptiform opercular syndrome: F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) findings and efficacy of levetiracetam therapy. ( Akın, R; Arslan, M; Ince, S; Ünay, B; Vurucu, S; Yiş, U, 2012)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goodwin, SJ1
Carpenter, AF1
Tuncer, S1
Sencan, A1
Aral, M1
Ayhan, S1
Arslan, M1
Yiş, U1
Vurucu, S1
Ince, S1
Ünay, B1
Akın, R1

Other Studies

3 other studies available for piracetam and Dysarthosis

ArticleYear
Successful treatment of paroxysmal ataxia and dysarthria in multiple sclerosis with levetiracetam.
    Multiple sclerosis and related disorders, 2016, Volume: 10

    Topics: Adult; Anticonvulsants; Brain; Dysarthria; Female; Humans; Levetiracetam; Magnetic Resonance Imaging

2016
Piracetam-induced dysarthria: an unusual complication of antithrombotic prophylaxis after toe to finger transfer.
    Journal of reconstructive microsurgery, 2011, Volume: 27, Issue:9

    Topics: Adult; Chemoprevention; Dysarthria; Fibrinolytic Agents; Finger Injuries; Humans; Male; Piracetam; P

2011
Acquired epileptiform opercular syndrome: F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) findings and efficacy of levetiracetam therapy.
    Epilepsy & behavior : E&B, 2012, Volume: 25, Issue:1

    Topics: Anticonvulsants; Child, Preschool; Deglutition Disorders; Dysarthria; Electroencephalography; Epilep

2012